Combination drug treatment of beingn prostatic hyperplasia (BPH

Abstract

Combination use of alpha-adrenergic blockers (tamsulocin or alfuzocin) and 5 alpha iso-enzyme 1&2 inhibitor (dutasteride) in symptomatic benign prostatic hyperplasia (BPH) is the best first optional mode of treatment giving good results with minimal treatment adverse effects especially for those at risk for surgical intervention and those who are still sexually active.